News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Serentis Acquires Atopic Dermatitis Company Surface Therapeutics



10/2/2007 8:54:33 AM

CAMBRIDGE, UK--(Marketwire - October 02, 2007) - Serentis, a UK-based biopharmaceutical company innovating, acquiring and developing dermatological and wound care products, announced today that it has completed the acquisition of Surface Therapeutics Ltd. ("Surface"). Surface has pioneered research into discovering novel, patented treatments for dermatological diseases.

Read at BioSpace.com


comments powered by Disqus
Serentis
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES